Estimated reading time: 5 minutes Key Takeaways Shares of Firefly Aerospace surged in their initial public offering debut, underscoring investor excitement for the space sector. The company raised nearly $870 …
-
-
Estimated reading time: 4 minutes Key Takeaways The Dow Jones Industrial Average slipped 224 points as tech strength failed to offset industrial weakness. Nasdaq finished higher, highlighting the ongoing *rotation* …
-
Estimated reading time: 4 minutes Key Takeaways Dow Jones Industrial Average (DJIA) closed at 44,193.12, gaining 81.38 points (+0.18%). Trading volume remained moderate, reflecting *steady risk appetite* across Wall Street. …
-
Estimated reading time: 7 minutes Key Takeaways The new executive order allows 401(k) investors to access alternative assets such as private equity, private credit, cryptocurrencies, real estate, and commodities. Regulators …
-
Estimated reading time: 6 minutes Key Takeaways The Trump tariff list reshaped U.S. trade policy, sparking a multi-year trade war. Section 232 duties on steel and aluminium were justified on …
-
Estimated reading time: 6 minutes Key Takeaways Soaring living costs and student debt are the twin forces most commonly delaying traditional adulthood markers. Only **one in four** 21-year-olds is fully …
-
Estimated reading time: 6 minutes Key Takeaways The Dow Jones Industrial Average added 81 points, closing within sight of its record high. A $100 billion Apple manufacturing pledge sparked a …
-
Estimated reading time: 6 minutes Key Takeaways Tech leadership endures: Apple’s 5.1 % jump, driven by its US$100 billion domestic-manufacturing pledge, powered the Dow higher. Uneven consumer results: McDonald’s climbed, Disney slipped, …
-
Estimated reading time: 6 minutes Key Takeaways Firefly Aerospace made a stellar Nasdaq debut under the FLY ticker, with shares soaring above the IPO price. The company upsized its IPO …
-
Estimated reading time: 4 minutes Key Takeaways Eli Lilly’s oral GLP-1 pill, orforglipron, delivered only 11-12% weight loss in its pivotal trial, lagging behind injectables. The news erased roughly US$100 billion …